Home › Funds › Lisanti Capital Growth, LLC › GRDN

Lisanti Capital Growth, LLC position in GRDN

GUARDIAN PHARMACY SVCS INC · Consumer Staples

Lisanti Capital Growth, LLC reported holding 147,435 shares of GRDN (GUARDIAN PHARMACY SVCS INC) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 1.61% of its reported portfolio and ranking #15 among its reported holdings. Lisanti Capital Growth, LLC has disclosed GRDN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)147.44K sh
Reported value held$6.01M
Portfolio Weight1.61%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Lisanti Capital Growth, LLC's GRDN position evolved

Lisanti Capital Growth, LLC first disclosed a stake in GRDN in Q1 2026 at 188,150 shares (US$7.1M). Across 3 filings, Lisanti Capital Growth, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 147,435 shares valued at US$6.0M — a reduction of -4,590 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 188.15K $7.09M New
Q2 2026 152.03K $6.37M Reduce
Q3 2026 147.44K $6.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GRDN and 13F data

GRDN (GUARDIAN PHARMACY SVCS INC) is a Consumer Staples company. 60 other funds we track also report a position in GRDN — the largest reported positions include Valiant Capital Management, L.P. (US$49.7M), BOONE CAPITAL MANAGEMENT LLC (US$29.8M), Aristotle Capital Boston, LLC (US$17.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GRDN

All GRDN fund holders →

FAQ

How long has Lisanti Capital Growth, LLC held GRDN?

Lisanti Capital Growth, LLC has disclosed GRDN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Lisanti Capital Growth, LLC's current position in GRDN?

As of Q3 2026, Lisanti Capital Growth, LLC holds 147.44K shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $6.01M, representing 1.61% of its reported portfolio and ranking #15.

Has Lisanti Capital Growth, LLC been buying or selling GRDN?

In the latest 13F filing (Q3 2026), Lisanti Capital Growth, LLC reduced its position in GRDN.

Which other funds hold GRDN?

Other major institutional holders of GRDN include Valiant Capital Management, L.P., BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.